GL1X · GenesisL1 explorer

Research workbench

Site-specific lysine arylation as an alternative bioconjugation strategy for chemically programmed antibodies and antibody-drug conjugates

Analyse Site-specific lysine arylation as an alternative bioconjugation strategy for… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6U85
Type
protein
Length
434 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Antibody Fab heavy chain; Antibody Fab light chain
Pockets
4 · best druggability 0.60

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 49% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HAntibody Fab heavy chainprotein2167% helix, 52% strand—
LAntibody Fab light chainprotein2187% helix, 46% strand—

Ligands and binding sites

  • GOL · Glycerol · additive · chains H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15330.600.7474empty
21590.440.7531empty
3900.380.7627empty
4530.260.7418empty

Interfaces

1 interface between chains.

  • H–L · 1853 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 6U85 · Site-specific lysine arylation as an alternative bioconjugation strategy for chemically… · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.